Background: Despite many studies showing a correlation between fast food consumption and non-alcoholic fatty liver disease (NAFLD) known as the silent death, few studies have investigated the effects of different types of fast foods on this disease. This research aimed to evaluate the effect of consuming different types of fast foods on non-alcoholic fatty liver disease. Materials and Methods:...

Introduction: Non-alcoholic fatty liver disease (NAFLD) has become the most common cause of liver disease worldwide. It has been suggested that dietary composition plays a role in NAFLD pathogenesis; thus, changing dietary patterns may constitute a therapeutic resource even in the absence of weight reduction. The aim of this study was to identify the characteristic of suitable dietary pattern i...

conclusions we assessed polysomnographic parameters of ahi, odi, laso2 and mean nocturnal spo2 levels, which are especially important in the association between nafld and osas. we think that it is necessary to be attentive regarding nafld development and progression in patients with osa whose nocturnal hypoxia is severe. patients and methods in this study, between december 2011 and december 201...

patients with psychiatric disorders are usually more exposed to multiple somatic illnesses, including liver diseases. specific links are established between psychiatric disorders and alcohol hepatitis, hepatitis b, and hepatitis c in the population as a whole, and specifically in drug abusers. metabolic syndrome criteria, and associated steatosis or non-alcoholic steato-hepatitis (nash) are fre...

no abstract

â  â  no treatment has been proven to be effective in nonalcoholic fatty liver disease (nafld) and/or steatohepatitis (nash). numerous studies have addressed this issue. however conclusive recommenâ­dations cannot be drawn solely from the currently available studies. hence we performed this systematic review to determine which of the available therapeutic modalities are supported by adequate ev...

background: nonalcoholic fatty liver disease (nafld) is becoming a significant problem especially through substantial increase in the incidence of obesity worldwide. currently it is the most common cause of abnormal serum aminotransferase levels both in low- and middle-income countries and in high-income countries and despite its high prevalence, well-defined screening recommendations are curre...

Background: Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) is a common public health problem. Visfatin is secreted by visceral adipose tissue and is an adipocytokine. It could be a pro-inflammatory adipocytokine and is related to the metabolic syndrome and non-alcoholic fatty liver disease. This study evaluated the association between visfatin levels in patients w...

Non-alcoholic fatty liver disease is now recognized as the hepatic component of the metabolic syndrome. Non-alcoholic fatty liver disease is a spectrum of fat-associated liver conditions that can result in end-stage liver disease and the need for liver transplantation. Simple steatosis, or fatty liver, occurs early in non-alcoholic fatty liver disease and may progress to non-alcoholic steatohep...